HomeCompareFSPKF vs QYLD

FSPKF vs QYLD: Dividend Comparison 2026

FSPKF yields 1.53% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FSPKF wins by $8.2K in total portfolio value
10 years
FSPKF
FSPKF
● Live price
1.53%
Share price
$23.02
Annual div
$0.35
5Y div CAGR
31.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.6K
Annual income
$3,544.59
Full FSPKF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — FSPKF vs QYLD

📍 FSPKF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFSPKFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FSPKF + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FSPKF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSPKF
Annual income on $10K today (after 15% tax)
$130.35/yr
After 10yr DRIP, annual income (after tax)
$3,012.90/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, QYLD beats the other by $1,797.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSPKF + QYLD for your $10,000?

FSPKF: 50%QYLD: 50%
100% QYLD50/50100% FSPKF
Portfolio after 10yr
$29.5K
Annual income
$4,601.96/yr
Blended yield
15.59%
📊

Analyst Conviction Gap

Where Wall Street is split right now

FSPKF
No analyst data
Price Target
$23.65
+2.7% upside vs current
Range: $21.30 — $26.00
Altman Z
26.1
Piotroski
7/9
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSPKF buys
0
QYLD buys
0
No recent congressional trades found for FSPKF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFSPKFQYLD
Forward yield1.53%11.92%
Annual dividend / share$0.35$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR31.2%0%
Portfolio after 10y$33.6K$25.4K
Annual income after 10y$3,544.59$5,659.31
Total dividends collected$11.9K$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: FSPKF vs QYLD ($10,000, DRIP)

YearFSPKF PortfolioFSPKF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$10,901$201.19$10,352$1,192.36+$549.00FSPKF
2$11,933$268.93$10,830$1,347.57+$1.1KFSPKF
3$13,130$360.97$11,460$1,539.07+$1.7KFSPKF
4$14,536$486.98$12,275$1,777.84+$2.3KFSPKF
5$16,214$661.07$13,323$2,078.95+$2.9KFSPKF
6$18,253$904.19$14,667$2,463.34+$3.6KFSPKF
7$20,779$1,248.12$16,396$2,960.57+$4.4KFSPKF
8$23,976$1,742.18$18,631$3,612.97+$5.3KFSPKF
9$28,119$2,464.85$21,548$4,482.15+$6.6KFSPKF
10$33,632$3,544.59$25,398$5,659.31+$8.2KFSPKF

FSPKF vs QYLD: Complete Analysis 2026

FSPKFStock

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Full FSPKF Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this FSPKF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSPKF vs SCHDFSPKF vs JEPIFSPKF vs OFSPKF vs KOFSPKF vs MAINFSPKF vs XYLDFSPKF vs JEPQFSPKF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.